» Articles » PMID: 28145402

Dysfunction of Ventrolateral Striatal Dopamine Receptor Type 2-expressing Medium Spiny Neurons Impairs Instrumental Motivation

Abstract

Impaired motivation is present in a variety of neurological disorders, suggesting that decreased motivation is caused by broad dysfunction of the nervous system across a variety of circuits. Based on evidence that impaired motivation is a major symptom in the early stages of Huntington's disease, when dopamine receptor type 2-expressing striatal medium spiny neurons (D2-MSNs) are particularly affected, we hypothesize that degeneration of these neurons would be a key node regulating motivational status. Using a progressive, time-controllable, diphtheria toxin-mediated cell ablation/dysfunction technique, we find that loss-of-function of D2-MSNs within ventrolateral striatum (VLS) is sufficient to reduce goal-directed behaviours without impairing reward preference or spontaneous behaviour. Moreover, optogenetic inhibition and ablation of VLS D2-MSNs causes, respectively, transient and chronic reductions of goal-directed behaviours. Our data demonstrate that the circuitry containing VLS D2-MSNs control motivated behaviours and that VLS D2-MSN loss-of-function is a possible cause of motivation deficits in neurodegenerative diseases.

Citing Articles

Striatal dopamine D2/D3 receptor regulation of human reward processing and behaviour.

Osugo M, Wall M, Selvaggi P, Zahid U, Finelli V, Chapman G Nat Commun. 2025; 16(1):1852.

PMID: 39984436 PMC: 11845780. DOI: 10.1038/s41467-025-56663-7.


Temporal and Potential Predictive Relationships between Sleep Spindle Density and Spike-and-Wave Discharges.

Abdelaal M, Kato T, Natsubori A, Tanaka K eNeuro. 2024; 11(9).

PMID: 39256042 PMC: 11412100. DOI: 10.1523/ENEURO.0058-24.2024.


Application of Optogenetics in Neurodegenerative Diseases.

Zhang Q, Li T, Xu M, Islam B, Wang J Cell Mol Neurobiol. 2024; 44(1):57.

PMID: 39060759 PMC: 11281982. DOI: 10.1007/s10571-024-01486-1.


A reinforcement learning model with choice traces for a progressive ratio schedule.

Ihara K, Shikano Y, Kato S, Yagishita S, Tanaka K, Takata N Front Behav Neurosci. 2024; 17:1302842.

PMID: 38268795 PMC: 10806202. DOI: 10.3389/fnbeh.2023.1302842.


Dopamine Receptor Type 2-Expressing Medium Spiny Neurons in the Ventral Lateral Striatum Have a Non-REM Sleep-Induce Function.

Kato T, Tanaka K, Natsubori A eNeuro. 2023; 10(9).

PMID: 37704366 PMC: 10540673. DOI: 10.1523/ENEURO.0327-23.2023.


References
1.
Marin R . Apathy: a neuropsychiatric syndrome. J Neuropsychiatry Clin Neurosci. 1991; 3(3):243-54. DOI: 10.1176/jnp.3.3.243. View

2.
Tanaka K, Matsui K, Sasaki T, Sano H, Sugio S, Fan K . Expanding the repertoire of optogenetically targeted cells with an enhanced gene expression system. Cell Rep. 2012; 2(2):397-406. DOI: 10.1016/j.celrep.2012.06.011. View

3.
Gossen M, Bujard H . Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A. 1992; 89(12):5547-51. PMC: 49329. DOI: 10.1073/pnas.89.12.5547. View

4.
Thompson J, Harris J, Sollom A, Stopford C, Howard E, Snowden J . Longitudinal evaluation of neuropsychiatric symptoms in Huntington's disease. J Neuropsychiatry Clin Neurosci. 2012; 24(1):53-60. DOI: 10.1176/appi.neuropsych.11030057. View

5.
Quian Quiroga R, Nadasdy Z, Ben-Shaul Y . Unsupervised spike detection and sorting with wavelets and superparamagnetic clustering. Neural Comput. 2004; 16(8):1661-87. DOI: 10.1162/089976604774201631. View